Your browser doesn't support javascript.
loading
Heparin Prowess: Favorable Vascular-Immune Reprogramming in Pancreatic Cancer.
Korc, Murray.
Affiliation
  • Korc M; Department of Developmental and Cell Biology, Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California.
Clin Cancer Res ; 29(13): 2348-2350, 2023 07 05.
Article in En | MEDLINE | ID: mdl-37099035
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Heparin Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Heparin Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication: